N˚ | Age* | Sex | Weight** | Hb*** | NSAID | Clinical Syndroms | Within the time limit |
|
Group Ai |
| |||||||
01 | 21 | F‡ | 52 | SC | ibu† | Rhinitis/pruritus/angio-oedema | within 15 mn |
|
02 | 16 | M‡‡ | 45 | SC | ibu | Rhinitis/asthma | within 15 to 30 mn |
|
03 | 19 | F | 52 | SC | ibu | Hypotension/dyspnoea | within 15 mn |
|
04 | 13 | F | 41 | SAFA2 | ibu | Angio-oedema | up to 6 hours |
|
05 | 30 | M | 58 | SSFA2 | ibu | Angio-oedema/dyspnoea | within 15 mn |
|
06 | 19 | M | 51 | SC | ibu | Asthma/rhinitis | within 15 mn |
|
07 | 15 | F | 43 | SSFA2 | ibu | Hypotension/dyspnoea | up to 1 hour |
|
08 | 30 | M | 52 | SSFA2 | ibu | Asthma/rhinitis | within 15 mn |
|
09 | 33 | M | 57 | SAFA2 | ibu | Rhinitis/pruritus/angio-oedema | within 15 mn |
|
10 | 16 | M | 50 | SC | ibu | Hypotension/dyspnoea | within 15 mn |
|
11 | 14 | M | 45 | SSFA2 | ibu | Rhinitis/pruritus/angio-oedema | within 15 to 30 mn |
|
Group Bd | ||||||||
12 | 18 | M | 51 | SC | dicl†† | Asthma/rhinitis | within 15 to 30 mn |
|
13 | 39 | M | 61 | SSFA2 | dicl | Angio-oedema/pruritus | within 30 mn to 1 hour |
|
14 | 27 | F | 55 | SC | dicl | Dyspnoea | within 15 to 30 mn |
|
15 | 20 | F | 48 | SAFA2 | dicl | pruritus/Hypotension/dyspnoea | within 15 to 30 mn |
|
16 | 28 | M | 59 | SC | dicl | Hypotension/dyspnoea | within 15 to 30 mn |
|
17 | 29 | F | 61 | SC | dicl | Hypotension/dyspnoea | within 15 mn |
|
18 | 12 | M | 38 | SAFA2 | dicl | Hypotension/dyspnoea | within 15 mn |
|
19 | 33 | M | 58 | SC | dicl | Rhinitis | within 15 mn |
|
20 | 15 | M | 42 | SSFA2 | dicl | Asthma | within 15 mn |
|
21 | 21 | M | 46 | SSFA2 | dicl | Rhinitis/pruritus/angio-oedema | within 30 mn to 1 hour |
|
22 | 35 | M | 57 | SSFA2 | dicl | Asthma | within 30 mn to 1 hour |
|